查看完整行情页>>

|

货币单位:美元(USD)

ATAI Life Sciences NV (atai)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Georgina H. Kilfoil Presently, Georgina H. Kilfoil holds the position of Vice President-Clinical Operations at ATAI Life Sciences NV. She previously was SVP-Product Development & Clinical Operations at Anthera Pharmaceuticals, Inc., Vice President-Alliances & Project Management at Peninsula Pharmaceuticals, Inc. and Chief Development Officer at Benitec Biopharma Ltd. Ms. Kilfoil received an undergraduate degree from the University of Bristol and an MBA from Australian Graduate School of Management.
Florian Brand Founder of 5 different companies, which include: ATAI Life Sciences NV, ATAI Life Sciences AG and EmpathBio, Inc. Florian Brand and is Chief Executive Officer for ATAI Life Sciences AG (which he founded in 2018) and Chief Executive Officer & Managing Director at ATAI Life Sciences NV (which he founded in 2018). He is also on the board of 8 other companies. In the past he occupied the position of Managing Director at Springlane GmbH and Chief Executive Officer for Perception Neuroscience, Inc. He received an undergraduate degree from Ludwig-Maximilians-Universität München and a graduate degree from ESCP Europe Campus London.
Kevin Craig Presently, Kevin Craig holds the position of Vice President-Clinical Development at ATAI Life Sciences NV. In his past career Dr. Craig occupied the position of Senior Director-Neuroscience at Labcorp Drug Development, Inc. and Head-Early Clinical Development at Jazz Pharmaceuticals, Inc. Kevin Craig received a graduate degree from the University of the Witwatersrand and a graduate degree from the University of Cambridge.
Samantha Bender Presently, Samantha Bender holds the position of Senior Project Manager-Research & Development at ATAI Life Sciences NV. In her past career she held the position of Senior Program Manager at Agios Pharmaceuticals, Inc. She received an undergraduate degree and a graduate degree from Northeastern University.
Michael Raven Michael Raven is Vice President-Operations for ATAI Life Sciences NV. In his past career Mr. Raven occupied the position of Chief of Staff, Head-Communications & Strategy at Bayer Pharmaceuticals. He received an undergraduate degree from WHU-Otto Beisheim School of Management.
Anne Johnson Currently, Anne Johnson holds the position of Chief Financial & Accounting Officer for ATAI Life Sciences NV. In her past career she was Vice President-Finance of Xanodyne Pharmaceuticals, Inc., Corporate Controller at Chimerix, Inc. and Controller for Aruvant Sciences, Inc. Ms. Johnson received an undergraduate degree from The University of North Carolina at Wilmington.
Chris Lee Currently, Chris Lee occupies the position of Director-Information Technology at ATAI Life Sciences NV. In his past career he occupied the position of Director-Information Technology & Infrastructure at PharMEDium Services LLC and Director-Information Technology Operations at American Academy of Orthopaedic Surgeons. Chris Lee received an undergraduate degree from Lewis University.
Srinivas G. Rao Srinivas G. Rao founded 5 companies, among them: ATAI Life Sciences NV, Kyalin Biosciences, Inc. and ATAI Life Sciences AG. Currently, Dr. Rao occupies the position of Chief Executive Officer at EntheogeniX Biosciences, Inc., Chief Scientific Officer of ATAI Life Sciences AG (which he founded in 2018), Chief Scientific Officer for Kures, Inc. (which he founded in 2019) (a subsidiary of ATAI Life Sciences AG) and Chief Scientific Officer for ATAI Life Sciences NV (which he founded in 2018). Srinivas G. Rao is also on the board of Perception Neuroscience, Inc. and Member of Society For Neuroscience and Member of American College of Neuropsychopharmacology. In his past career Dr. Rao occupied the position of Chief Scientific Officer of Sova Pharmaceuticals, Inc., Chief Medical Officer at Axial Therapeutics, Inc., Member of American Pain Society, Executive VP & Head-Neuroscience Division at Travere Therapeutics, Inc. and Chief Executive Officer of Kyalin Biosciences, Inc. (a subsidiary of Travere Therapeutics, Inc.), Chief Scientific Officer & Science Director at Cypress Bioscience, Inc., Chief Medical Officer & Senior Vice President of Assertio Therapeutics, Inc., Chief Medical Officer of GABA Therapeutics, Inc. and Member of International Association for the Study of Pain. Srinivas G. Rao received a doctorate from Yale School of Medicine and a doctorate from Yale Graduate School of Arts & Sciences.
Christian Angermayer Mr. Christian Angermayer is a Co-Founder & General Partner at Elevat3 Capital Ltd., a Chairman at Cambrian BioPharma, Inc., a Chairman-Supervisory Board at ATAI Life Sciences NV, a Founder at Presight Capital, a Founder at Apeiron Investment Group Ltd. /Private Equity/, a Chairman-Supervisory Board at Film House Germany AG, a Co-Managing Director at First Sodalith Beteiligungsverwaltungsgesellschaft mbH, a Chief Executive & Director at Frontier Acquisition Corp., a Co-Founder & General Partner at re.Mind Capital Ltd., a Court Member at London School of Hygiene & Tropical Medicine, a General Manager at PA Beteiligungsgesellschaft mbH, a Member at Bill, Hillary & Chelsea Clinton Foundation, a Member at Milken Institute Young Leaders Circle, a Member-Young Global Leaders at The World Economic Forum USA, Inc., a Partner at Munich Security Conference Foundation and a Vice Chairman-Supervisory Board at Cinema for Peace Foundation. He is on the Board of Directors at BIT - Beteiligungs- & Investitions - Treuhand AG, Frontier Acquisition Corp., Blackrock Microsystems, Inc. and Cinema for Peace Foundation. Mr. Angermayer was previously employed as a Member-Supervisory Board by The Naga Group AG, a Founder by Batelle, Inc., a Co-Founder by ATAI Life Sciences AG, a Member-Supervisory Board by DEAG Deutsche Entertainment AG, a Member-Supervisory Board by Westend Brokers AG, a Member-Supervisory Board by CH2 Contorhaus Hansestadt Hamburg AG, a Deputy Chairman-Supervisory Board by FinLab AG, a Member-Supervisory Board by C-QUADRAT Investment AG, a Member-Supervisory Board by Silvia Quandt & Cie AG, a Chairman-Supervisory Board by ADC African Development Corp. GmbH & Co. KGaA, a Managing Director by ABL Consulting & Advisory GmbH,
Sahil Kirpekar Sahil Kirpekar is on the board of IntelGenx Technologies Corp. and Head-Business Development for Otsuka Pharmaceutical Co., Ltd. and Chief Business Officer for ATAI Life Sciences NV. He received a graduate degree from the University of Cambridge.
Frank Stegert Founder of 99chairs GmbH, Frank Stegert presently occupies the position of VP-Investment Management & Operations at ATAI Life Sciences AG and Vice President-Investment Management at ATAI Life Sciences NV. In his past career he held the position of Senior Vice President & Head-Fund Banking at Deutsche Handelsbank AG and Managing Director at 99chairs GmbH. Frank Stegert received an undergraduate degree from Technische Universität München.
Arvind Tewari Arvind Tewari occupies the position of Vice President-Digital Strategy & Operations at ATAI Life Sciences NV and Investment Manager at Epiris Managers LLP. Mr. Tewari previously was Chief Executive & Operating Officer at Oxford VR Ltd. Mr. Tewari received an undergraduate degree and a graduate degree from the University of Oxford.
Rolando Gutíerrez-Esteinou Presently, Rolando Gutíerrez-Esteinou occupies the position of Chief Medical Officer at ATAI Life Sciences NV. He previously occupied the position of Senior Vice President-Medical & Pharmacovigilance at Aptinyx, Inc., VP-Clinical Development & Pharmacovigilance at Marinus Pharmaceuticals, Inc., Executive Director & VP-Global Therapeutic at Takeda Pharmaceutical Co., Ltd. and Vice President-Global Therapeutic Area at Labcorp Clinical Development GmbH. He received a doctorate from Universidad Nacional Autónoma de México.